These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38268853)

  • 1. Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies.
    Liao YL; Zhu GY; Chang C
    Front Cardiovasc Med; 2023; 10():1291438. PubMed ID: 38268853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation.
    Zhou BG; Ju SY; Mei YZ; Jiang X; Wang M; Zheng AJ; Ding YB
    Front Endocrinol (Lausanne); 2023; 14():1160532. PubMed ID: 37476492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Alon L; Corica B; Raparelli V; Cangemi R; Basili S; Proietti M; Romiti GF
    Eur J Prev Cardiol; 2022 May; 29(6):938-946. PubMed ID: 34939092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Wang L; Sang B; Zheng Z
    Front Aging Neurosci; 2022; 14():985109. PubMed ID: 36204558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking cessation for secondary prevention of cardiovascular disease.
    Wu AD; Lindson N; Hartmann-Boyce J; Wahedi A; Hajizadeh A; Theodoulou A; Thomas ET; Lee C; Aveyard P
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014936. PubMed ID: 35938889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Independent Association of Non-alcoholic Fatty Liver Disease With Incident Cardiovascular Disease: A GRADE Evaluation of the Evidence Through a Systematic Review and Meta-analysis.
    Prasad M; Gupta S; Sarin SK
    J Clin Exp Hepatol; 2024; 14(1):101277. PubMed ID: 38076375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between non-alcoholic fatty liver disease and coronary artery disease outcomes: A systematic review and meta-analysis.
    Abosheaishaa H; Hussein M; Ghallab M; Abdelhamid M; Balassiano N; Ahammed MR; Baig MA; Khan J; Elshair M; Soliman MY; Abdelwahed M; Ali A; Alzamzamy A; Nassar M
    Diabetes Metab Syndr; 2024 Jan; 18(1):102938. PubMed ID: 38194827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Liang C; Yu Z; Bai L; Hou W; Tang S; Zhang W; Chen X; Hu Z; Duan Z; Zheng S
    Front Endocrinol (Lausanne); 2022; 13():869579. PubMed ID: 35937795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Non-alcoholic Fatty Liver Disease and Risk of Stroke: A Systematic Review and Meta-Analysis.
    Wang M; Zhou BG; Zhang Y; Ren XF; Li L; Li B; Ai YW
    Front Cardiovasc Med; 2022; 9():812030. PubMed ID: 35345491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease and coexisting depression, anxiety and/or stress in adults: a systematic review and meta-analysis.
    Shea S; Lionis C; Kite C; Lagojda L; Uthman OA; Dallaway A; Atkinson L; Chaggar SS; Randeva HS; Kyrou I
    Front Endocrinol (Lausanne); 2024; 15():1357664. PubMed ID: 38689730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis.
    Houttu V; Bouts J; Vali Y; Daams J; Grefhorst A; Nieuwdorp M; Holleboom AG
    Front Endocrinol (Lausanne); 2022; 13():1032164. PubMed ID: 36407307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
    Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of occupational exposure to noise on ischaemic heart disease, stroke and hypertension: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-Related Burden of Disease and Injury.
    Teixeira LR; Pega F; Dzhambov AM; Bortkiewicz A; da Silva DTC; de Andrade CAF; Gadzicka E; Hadkhale K; Iavicoli S; Martínez-Silveira MS; Pawlaczyk-Łuszczyńska M; Rondinone BM; Siedlecka J; Valenti A; Gagliardi D
    Environ Int; 2021 Sep; 154():106387. PubMed ID: 33612311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of different exercise modalities on metabolic profiles and liver functions in non-alcoholic fatty liver disease: a network meta-analysis.
    Huang M; Yang J; Wang Y; Wu J
    Front Physiol; 2024; 15():1428723. PubMed ID: 39376897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis.
    Wu S; Wu F; Ding Y; Hou J; Bi J; Zhang Z
    Sci Rep; 2016 Sep; 6():33386. PubMed ID: 27633274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Global Prevalence of Nonalcoholic Fatty Liver Disease and its Association With Cancers: Systematic Review and Meta-Analysis.
    Muhamad NA; Maamor NH; Leman FN; Mohamad ZA; Bakon SK; Abdul Mutalip MH; Rosli IA; Aris T; Lai NM; Abu Hassan MR
    Interact J Med Res; 2023 Jul; 12():e40653. PubMed ID: 37467012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between metabolic dysfunction-associated steatotic liver disease and risk of colorectal cancer or colorectal adenoma: an updated meta-analysis of cohort studies.
    Zhao JF; Zhou BG; Lv Y; Teng QP; Wang XM; Li XY; Ding Y
    Front Oncol; 2024; 14():1368965. PubMed ID: 39045565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose-response meta-analysis.
    Ling Q; Chen J; Liu X; Xu Y; Ma J; Yu P; Zheng K; Liu F; Luo J
    Front Endocrinol (Lausanne); 2022; 13():1043169. PubMed ID: 36743937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.